Sublingual MV140 for Prevention of Recurrent Urinary Tract Infections.
Lorenzo-Gómez MF, Foley S, Nickel JC, García-Cenador MB, Padilla-Fernández BY, González-Casado I, Martínez-Huélamo M, Yang B, Blick C, Ferreira F, Caballero R, Saz-Leal P, Casanovas M.
Lorenzo-Gómez MF, et al. Among authors: nickel jc.
NEJM Evid. 2022 Apr;1(4):EVIDoa2100018. doi: 10.1056/EVIDoa2100018. Epub 2022 Jan 21.
NEJM Evid. 2022.
PMID: 38319200
Clinical Trial.